SpaceX's Starship Explodes After Launch over Caribbean

A 30-year-old pregnant woman, Adriana Smith, has been on life support for over three months following her declaration of brain death after a medical emergency in February. Her family reports that Smith's support is being sustained to allow her fetus to develop, in accordance with Georgia's strict anti-abortion law, which prohibits abortions after cardiac activity is detected, typically around six weeks of pregnancy. According to Smith's mother, April Newkirk, the decision to keep her on life support is complicated by the risk of removing the medical devices, which would likely result in the fetus's death. Smith is currently 21 weeks pregnant and the fetus has reportedly been diagnosed with fluid on the brain, raising concerns about its health prospects. Emory Healthcare, where Smith is being treated, stated they could not comment on individual cases but ensure compliance with Georgia's abortion laws in their medical practices. Advocates, including Monica Simpson of SisterSong, criticized the situation, arguing that Smith's family should have the power to make medical decisions regarding her care and lamenting the emotional toll the circumstances have imposed on them.

In a groundbreaking medical first, doctors in the United States have successfully treated an infant with a severe genetic disorder using custom gene-editing therapy. The child, referred to as KJ, was diagnosed with CPS1 deficiency, a rare condition that drastically impacts ammonia processing and affects approximately one in 1.3 million individuals. Experts estimate that around half of those afflicted do not survive past infancy. Specialists from the Children’s Hospital of Philadelphia and the University of Pennsylvania developed the therapy after KJ's diagnosis, implementing the complex process within six months. KJ received his first infusion in February, followed by two additional doses in March and April. According to Dr. Rebecca Ahrens-Nicklas, a senior physician involved in the treatment, KJ is currently thriving and has experienced an increased dietary tolerance and reduced medication needs. Details of the treatment, which involves advanced base editing technology, were published in the New England Journal of Medicine. While the therapy shows promise, researchers emphasize the importance of ongoing monitoring for KJ's long-term health outcomes.

A recent report has revealed that over 100 brands of store-bought rice in the United States contain dangerously high levels of arsenic and cadmium. According to Jane Houlihan, research director for Healthy Babies, Bright Futures, these heavy metals are linked to serious health issues such as diabetes, developmental delays, and heart disease. The report highlights that one in four rice samples exceeded the FDA's 2021 limit for inorganic arsenic in infant rice cereal, which is set at 100 parts per billion. The study noted that rice is the leading source of arsenic exposure for young children aged 0 to 2, surpassing infant cereals. Heavy metal contamination raises significant concerns for children’s development, leading to cognitive problems and lifelong health risks, as emphasized by the American Academy of Pediatrics. The USA Rice Federation contends that U.S. rice has some of the lowest levels of inorganic arsenic globally but acknowledges ongoing collaboration with the FDA to ensure safety standards are met. Experts recommend cooking rice like pasta to reduce arsenic levels significantly and suggest more stringent labeling to inform consumers about the origins of rice products.